Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ...

Steffen Lang, president, operations, executive committee member, Novartis, discusses what to expect from Novartis over the next decade in terms of technological innovations.

Vertex' portfolio has been steadily expanded with new product launches to cover the ... a majority stake in cell therapy start-up Aurion Biotech, replacing the company's chief executive.